Produse farmaceutice
Information about customer
Title
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
IDNO
1016601000212
Address
MOLDOVA,
locality,
MD-2009, Republica Moldova, Chişinău str. Cosmescu 3,
MD-2009
The contact person
Macari Doina,
doina.macari@capcs.md
Purchase data
ID
ocds-b3wdp1-MD-1666868230427
Title
Produse farmaceutice
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1666868232014
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1666870784365
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1667820636354
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1667820636505
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1668170194089
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1668170194247
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670342620349
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670342620522
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670342620870
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670342620697
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670342621049
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670342620202
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670487416255
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670487416445
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670487415501
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670487415702
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670487415882
IBAN
None
Funding source cost
3836394.48 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666868230427-FS-1670487416056
IBAN
None
Status Planning
Start the procedure:
1 Jan 2023
1 Jan 2024
Date of publication: 27 Oct 2022 13:58
Date of last modifications: 20 Dec 2022 18:36